Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

CGS Insider Trading (Cogstate)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$2,467,750.00

Cogstate Insider Trading History Chart

This chart shows the insider buying and selling history at Cogstate by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cogstate Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CGS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

Cogstate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2021Martyn MyerInsiderSell250,000A$1.77A$442,750.00
3/23/2021Bradley O'ConnorInsiderExercise750,000A$0.84A$630,000.00
3/9/2021Bradley O'ConnorInsiderSell2,250,000A$0.90A$2,025,000.00
11/2/2020Bradley O'ConnorInsiderIssued1,250,000A$1.11A$1,387,500.00
3/13/2020Bradley O'ConnorInsiderBuy1,100,000A$0.21A$231,000.00
See Full Table
Insider Selling at Cogstate?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cogstate and related companies.

SEC Filings (Institutional Ownership Changes) for Cogstate (ASX:CGS)

Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2020, it had participated in approximately 1,800 academic research studies in approximately 200 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is based in Fitzroy, Australia.
Read More on Cogstate

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,002 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cogstate?

Cogstate's top insider investors include:
  1. Bradley O'Connor (Insider)
  2. Martyn Myer (Insider)
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more